Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
58.43
+4.08 (+7.51%)
Streaming Delayed Price
Updated: 10:36 AM EDT, May 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Today 10:05 EDT
Via
Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
Today 9:55 EDT
Via
Investor Brand Network
Topics
Intellectual Property
What's going on in today's pre-market session: S&P500 movers
↗
Today 8:35 EDT
Via
Chartmill
These S&P500 stocks have an unusual volume in today's session
↗
May 08, 2026
Via
Chartmill
Moderna Inc (NASDAQ:MRNA) Surges Past Q1 Estimates on International Strength
↗
May 01, 2026
Via
Chartmill
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Today 8:30 EDT
From
BioMedWire
Via
GlobeNewswire
3 Cash-Heavy Stocks with Warning Signs
Today 0:40 EDT
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Via
StockStory
Moderna (MRNA) Shares Skyrocket, What You Need To Know
May 08, 2026
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 10.2% in the afternoon session after the company published positive Phase 3 clini...
Via
StockStory
Topics
Intellectual Property
Explore the top gainers and losers within the S&P500 index in today's session.
↗
May 08, 2026
Via
Chartmill
Which S&P500 stocks are moving on Friday?
↗
May 08, 2026
Via
Chartmill
Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know
↗
May 08, 2026
Moderna Inc (NASDAQ: MRNA) shares are trading higher Friday morning as traders react to peer reviewed Phase 3 flu-vaccine data.
Via
Benzinga
5 Insightful Analyst Questions From Moderna’s Q1 Earnings Call
May 08, 2026
Moderna’s first quarter was marked by a sharp increase in revenue, driven by the fulfillment of large international contracts, particularly through a strateg...
Via
StockStory
Topics
Earnings
Intellectual Property
Moderna Stock Gives Back Early Gains: What's Happening?
↗
May 07, 2026
Moderna, Inc. (NASDAQ:MRNA) shares initially surged Thursday, but have since retreated after the company announced the publication of its Phase 3 study results evaluating mRNA -1010 in the New England...
Via
Benzinga
Top S&P500 movers in Thursday's pre-market session
↗
May 07, 2026
Via
Chartmill
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
May 06, 2026
Via
ACCESS Newswire
These S&P500 stocks are moving in today's session
↗
May 04, 2026
Via
Chartmill
Exploring the top movers within the S&P500 index during today's session.
↗
May 04, 2026
Via
Chartmill
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds
May 02, 2026
Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 260% year on year to $389 mil...
Via
StockStory
These S&P500 stocks are moving in today's session
↗
May 01, 2026
Via
Chartmill
Moderna (MRNA) Q1 2026 Earnings Transcript
↗
May 01, 2026
Moderna (MRNA) Q1 2026 Earnings Transcript
Via
The Motley Fool
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars
May 01, 2026
Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 260% year on year to $389 mi...
Via
StockStory
What's going on in today's pre-market session: S&P500 movers
↗
May 01, 2026
Via
Chartmill
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
May 01, 2026
Via
ACCESS Newswire
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect
April 29, 2026
Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday morning. Here’s what you need to know. Moderna beat analysts’ revenue expec...
Via
StockStory
These S&P500 stocks are gapping in today's session
↗
April 24, 2026
Via
Chartmill
3 Healthcare Stocks With the Most Durable Competitive Moats
↗
April 23, 2026
These companies offer a clear path to sustained earnings growth.
Via
The Motley Fool
Topics
Intellectual Property
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
April 21, 2026
Via
ACCESS Newswire
Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth
↗
April 21, 2026
It will be a turbulent ride, but patient investors might come out of it much richer.
Via
The Motley Fool
Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
April 21, 2026
Via
ACCESS Newswire
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
April 21, 2026
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
